Exact Mass: 646.4556782

Exact Mass Matches: 646.4556782

Found 500 metabolites which its exact mass value is equals to given mass value 646.4556782, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Glycerol 1-(9Z-octadecenoate) 2-tetradecanoate 3-phosphate

Glycerol 1-(9Z-octadecenoic acid) 2-tetradecanoic acid 3-phosphoric acid

C35H67O8P (646.4573312)


Surfactants, used as food emulsifiers. [CCD]. Surfactants, used as food emulsifiers. [CCD

   

PA(16:1(9Z)/16:0)

[(2R)-3-[(9Z)-hexadec-9-enoyloxy]-2-(hexadecanoyloxy)propoxy]phosphonic acid

C35H67O8P (646.4573312)


PA(16:1(9Z)/16:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(16:1(9Z)/16:0), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of palmitic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(18:0/14:1(9Z))

[(2R)-3-(octadecanoyloxy)-2-[(9Z)-tetradec-9-enoyloxy]propoxy]phosphonic acid

C35H67O8P (646.4573312)


PA(18:0/14:1(9Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(18:0/14:1(9Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(18:1(11Z)/14:0)

[(2R)-3-[(11Z)-octadec-11-enoyloxy]-2-(tetradecanoyloxy)propoxy]phosphonic acid

C35H67O8P (646.4573312)


PA(18:1(11Z)/14:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(18:1(11Z)/14:0), in particular, consists of one chain of cis-vaccenic acid at the C-1 position and one chain of myristic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(18:1(9Z)/14:0)

[(2R)-3-[(9Z)-octadec-9-enoyloxy]-2-(tetradecanoyloxy)propoxy]phosphonic acid

C35H67O8P (646.4573312)


PA(18:1(9Z)/14:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(18:1(9Z)/14:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of myristic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(13:0/18:1(12Z)-O(9S,10R))

[(2R)-2-[(8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoyl)oxy]-3-(tridecanoyloxy)propoxy]phosphonic acid

C34H63O9P (646.4209478)


PA(13:0/18:1(12Z)-O(9S,10R)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(13:0/18:1(12Z)-O(9S,10R)), in particular, consists of one chain of one tridecanoyl at the C-1 position and one chain of 9,10-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(18:1(12Z)-O(9S,10R)/13:0)

[(2R)-3-[(8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoyl)oxy]-2-(tridecanoyloxy)propoxy]phosphonic acid

C34H63O9P (646.4209478)


PA(18:1(12Z)-O(9S,10R)/13:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-O(9S,10R)/13:0), in particular, consists of one chain of one 9,10-epoxy-octadecenoyl at the C-1 position and one chain of tridecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(13:0/18:1(9Z)-O(12,13))

[(2R)-2-{[(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy}-3-(tridecanoyloxy)propoxy]phosphonic acid

C34H63O9P (646.4209478)


PA(13:0/18:1(9Z)-O(12,13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(13:0/18:1(9Z)-O(12,13)), in particular, consists of one chain of one tridecanoyl at the C-1 position and one chain of 12,13-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(18:1(9Z)-O(12,13)/13:0)

[(2R)-3-{[(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy}-2-(tridecanoyloxy)propoxy]phosphonic acid

C34H63O9P (646.4209478)


PA(18:1(9Z)-O(12,13)/13:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(9Z)-O(12,13)/13:0), in particular, consists of one chain of one 12,13-epoxy-octadecenoyl at the C-1 position and one chain of tridecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(a-13:0/18:1(12Z)-O(9S,10R))

[(2R)-3-[(10-methyldodecanoyl)oxy]-2-[(8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoyl)oxy]propoxy]phosphonic acid

C34H63O9P (646.4209478)


PA(a-13:0/18:1(12Z)-O(9S,10R)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(a-13:0/18:1(12Z)-O(9S,10R)), in particular, consists of one chain of one 10-methyldodecanoyl at the C-1 position and one chain of 9,10-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(18:1(12Z)-O(9S,10R)/a-13:0)

[(2R)-2-[(10-methyldodecanoyl)oxy]-3-[(8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoyl)oxy]propoxy]phosphonic acid

C34H63O9P (646.4209478)


PA(18:1(12Z)-O(9S,10R)/a-13:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-O(9S,10R)/a-13:0), in particular, consists of one chain of one 9,10-epoxy-octadecenoyl at the C-1 position and one chain of 10-methyldodecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(a-13:0/18:1(9Z)-O(12,13))

[(2R)-3-[(10-methyldodecanoyl)oxy]-2-{[(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy}propoxy]phosphonic acid

C34H63O9P (646.4209478)


PA(a-13:0/18:1(9Z)-O(12,13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(a-13:0/18:1(9Z)-O(12,13)), in particular, consists of one chain of one 10-methyldodecanoyl at the C-1 position and one chain of 12,13-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(18:1(9Z)-O(12,13)/a-13:0)

[(2R)-2-[(10-methyldodecanoyl)oxy]-3-{[(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy}propoxy]phosphonic acid

C34H63O9P (646.4209478)


PA(18:1(9Z)-O(12,13)/a-13:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(9Z)-O(12,13)/a-13:0), in particular, consists of one chain of one 12,13-epoxy-octadecenoyl at the C-1 position and one chain of 10-methyldodecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(i-13:0/18:1(12Z)-O(9S,10R))

[(2R)-3-[(11-methyldodecanoyl)oxy]-2-[(8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoyl)oxy]propoxy]phosphonic acid

C34H63O9P (646.4209478)


PA(i-13:0/18:1(12Z)-O(9S,10R)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(i-13:0/18:1(12Z)-O(9S,10R)), in particular, consists of one chain of one 11-methyldodecanoyl at the C-1 position and one chain of 9,10-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(18:1(12Z)-O(9S,10R)/i-13:0)

[(2R)-2-[(11-methyldodecanoyl)oxy]-3-[(8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoyl)oxy]propoxy]phosphonic acid

C34H63O9P (646.4209478)


PA(18:1(12Z)-O(9S,10R)/i-13:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-O(9S,10R)/i-13:0), in particular, consists of one chain of one 9,10-epoxy-octadecenoyl at the C-1 position and one chain of 11-methyldodecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(i-13:0/18:1(9Z)-O(12,13))

[(2R)-3-[(11-methyldodecanoyl)oxy]-2-{[(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy}propoxy]phosphonic acid

C34H63O9P (646.4209478)


PA(i-13:0/18:1(9Z)-O(12,13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(i-13:0/18:1(9Z)-O(12,13)), in particular, consists of one chain of one 11-methyldodecanoyl at the C-1 position and one chain of 12,13-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(18:1(9Z)-O(12,13)/i-13:0)

[(2R)-2-[(11-methyldodecanoyl)oxy]-3-{[(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy}propoxy]phosphonic acid

C34H63O9P (646.4209478)


PA(18:1(9Z)-O(12,13)/i-13:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(9Z)-O(12,13)/i-13:0), in particular, consists of one chain of one 12,13-epoxy-octadecenoyl at the C-1 position and one chain of 11-methyldodecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

DG(16:0/PGJ2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxy}propyl hexadecanoic acid

C39H66O7 (646.4808286)


DG(16:0/PGJ2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/PGJ2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(PGJ2/16:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxy}propan-2-yl hexadecanoic acid

C39H66O7 (646.4808286)


DG(PGJ2/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGJ2/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(16:0/0:0/PGJ2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxy}propyl hexadecanoic acid

C39H66O7 (646.4808286)


DG(16:0/0:0/PGJ2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(PGJ2/0:0/16:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxy}propyl hexadecanoic acid

C39H66O7 (646.4808286)


DG(PGJ2/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-16:0/PGJ2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxy}propyl 14-methylpentadecanoic acid

C39H66O7 (646.4808286)


DG(i-16:0/PGJ2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/PGJ2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(PGJ2/i-16:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxy}propan-2-yl 14-methylpentadecanoic acid

C39H66O7 (646.4808286)


DG(PGJ2/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGJ2/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-16:0/0:0/PGJ2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxy}propyl 14-methylpentadecanoic acid

C39H66O7 (646.4808286)


DG(i-16:0/0:0/PGJ2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(PGJ2/0:0/i-16:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxy}propyl 14-methylpentadecanoic acid

C39H66O7 (646.4808286)


DG(PGJ2/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

dipalmitoyl phosphatidate

1-(Hexadecanoyloxy)-3-(phosphonatooxy)propan-2-yl hexadecanoic acid

C35H67O8P (646.4573312)


Dipalmitoyl phosphatidate, also known as 1,2-dipalmitoyl-sn-glycero-3-phosphoric acid(2-) or 1,2-dihexadecanoylglycero-3-phosphate(2-), is a member of the class of compounds known as 1,2-diacylglycerol-3-phosphates. 1,2-diacylglycerol-3-phosphates are glycerol-3-phosphates in which the glycerol moiety is bonded to two aliphatic chains through ester linkages. Dipalmitoyl phosphatidate is practically insoluble (in water) and a moderately acidic compound (based on its pKa). Dipalmitoyl phosphatidate can be found in a number of food items such as cocoa bean, shiitake, japanese persimmon, and jerusalem artichoke, which makes dipalmitoyl phosphatidate a potential biomarker for the consumption of these food products.

   
   

(+)-12alpha,28-Dihydroxy-3alpha-(3-hydroxy-3-methylglutaryloxy)-24-methyllanosta-8,24(31)-dien-26-oic acid

(+)-12alpha,28-Dihydroxy-3alpha-(3-hydroxy-3-methylglutaryloxy)-24-methyllanosta-8,24(31)-dien-26-oic acid

C37H58O9 (646.4080618)


   
   
   
   

3-O-beta-D-xylopyranosyl-16beta-acetoxyholost-7-ene

3-O-beta-D-xylopyranosyl-16beta-acetoxyholost-7-ene

C37H58O9 (646.4080618)


   

micromonospolide B

micromonospolide B

C37H58O9 (646.4080618)


   

Oleanolic acid-3-O-??-D-(6-O-methyl)-glucuronoside

Oleanolic acid-3-O-??-D-(6-O-methyl)-glucuronoside

C37H58O9 (646.4080618)


   

25-methoxy-5beta,19-epoxycucurbita-6,23-dien-19-on-3beta-ol 3-O-beta-D-glucopyranoside|karaviloside VI

25-methoxy-5beta,19-epoxycucurbita-6,23-dien-19-on-3beta-ol 3-O-beta-D-glucopyranoside|karaviloside VI

C37H58O9 (646.4080618)


   
   

3-O-(2-O-Acetyl-alpha-L-arabinopyranoside)-3,23-Dihydroxy-12-oleanen-28-oic acid

3-O-(2-O-Acetyl-alpha-L-arabinopyranoside)-3,23-Dihydroxy-12-oleanen-28-oic acid

C37H58O9 (646.4080618)


   

3beta-hydroxyurs-12-en-28-oic acid 3-O-beta-D-glucuranopyranoside 6-O-methyl ester

3beta-hydroxyurs-12-en-28-oic acid 3-O-beta-D-glucuranopyranoside 6-O-methyl ester

C37H58O9 (646.4080618)


   
   

3beta-O-cis-ferulyl-2alpha-hydroxy-urs-12-en-28-oic acid

3beta-O-cis-ferulyl-2alpha-hydroxy-urs-12-en-28-oic acid

C41H58O6 (646.4233168000001)


   

28-acetoxy-olean-12-en-3beta-yl trans-caffeate

28-acetoxy-olean-12-en-3beta-yl trans-caffeate

C41H58O6 (646.4233168000001)


   

3-[(2-O-acetyl-beta-D-xylopyranosyl)oxy]-19-hydroxyurs-12-en-28-oic acid|ilexasprellanoside B

3-[(2-O-acetyl-beta-D-xylopyranosyl)oxy]-19-hydroxyurs-12-en-28-oic acid|ilexasprellanoside B

C37H58O9 (646.4080618)


   

14alpha,15alpha,16alpha,17alpha,18alpha,19alpha,20alpha,21alpha-octahydroxy-16,17,18-trimethyl-n-triacontan-trans,trans-22,24-dien-1-oic acid

14alpha,15alpha,16alpha,17alpha,18alpha,19alpha,20alpha,21alpha-octahydroxy-16,17,18-trimethyl-n-triacontan-trans,trans-22,24-dien-1-oic acid

C35H66O10 (646.4655736)


   

(19alpha)-3-[(2-O-acetyl-beta-D-xylopyranosyl)oxy]-19-hydroxyolean-12-en-28-oic acid|ilexasprellanoside E

(19alpha)-3-[(2-O-acetyl-beta-D-xylopyranosyl)oxy]-19-hydroxyolean-12-en-28-oic acid|ilexasprellanoside E

C37H58O9 (646.4080618)


   

Fomitoside E

Fomitoside E

C37H58O9 (646.4080618)


A triterpene glycoside that consists of lanost-8,23-dien-21-oic acid substituted at by a alpha-acetyloxy group at position 3, a hydroxy group at position 25 and a beta-D-xylopyranosyl moiety at position 21 via a glycosidic linkage. Isolated from the fruit body of Fomitopsis pinicola, it exhibits inhibitory activity against COX-1 and COX-2.

   

ent-Kaur-16-en-15beta-yl ent-labda-8(17),13-dien-15-yl malonate

ent-Kaur-16-en-15beta-yl ent-labda-8(17),13-dien-15-yl malonate

C43H66O4 (646.4960836)


   

3-O-acetyl-3-O-alpha-L-arabinopyranosyl hederagenin|3-O-acetyl-3-O-alpha-L-arabinosyl-23-hydroxyolean-12-en-28-oic acid

3-O-acetyl-3-O-alpha-L-arabinopyranosyl hederagenin|3-O-acetyl-3-O-alpha-L-arabinosyl-23-hydroxyolean-12-en-28-oic acid

C37H58O9 (646.4080618)


   

4-O-acetyl-3-O-alpha-L-arabinopyranosyl hederagenin|4-O-acetyl-3-O-alpha-L-arabinosyl-23-hydroxyolean-12-en-28-oic acid

4-O-acetyl-3-O-alpha-L-arabinopyranosyl hederagenin|4-O-acetyl-3-O-alpha-L-arabinosyl-23-hydroxyolean-12-en-28-oic acid

C37H58O9 (646.4080618)


   

Cloversaponin I methyl ester

Cloversaponin I methyl ester

C37H58O9 (646.4080618)


   

SM d30:1

SM d30:1

C35H71N2O6P (646.5049475999999)


Found in mouse brain; TwoDicalId=391; MgfFile=160720_brain_AA_18_Neg; MgfId=519 Found in mouse spleen; TwoDicalId=249; MgfFile=160729_spleen_DHA_12_Neg; MgfId=564

   

PE-Cer(d14:1/19:0)

N-(nonadecanoyl)-tetradecasphing-4-enine-1-phosphoethanolamine

C35H71N2O6P (646.5049475999999)


   

PE-Cer(d15:1/18:0)

N-(octadecanoyl)-pentadecasphing-4-enine-1-phosphoethanolamine

C35H71N2O6P (646.5049475999999)


   

PE-Cer(d14:2(4E,6E)/18:0(2OH))

N-(2-hydroxy-octadecanoyl)-4E,6E-tetradecasphingadienine-1-phosphoethanolamine

C34H67N2O7P (646.4685642)


   

PE-Cer(d16:2(4E,6E)/16:0(2OH))

N-(2-hydroxy-hexadecanoyl)-4E,6E-hexadecasphingadienine-1-phosphoethanolamine

C34H67N2O7P (646.4685642)


   

PA(14:0/18:1)

9-Octadecenoic acid (Z)-, 1-[[(1-oxotetradecyl)oxy]methyl]-2-(phosphonooxy)ethyl ester, (R)-

C35H67O8P (646.4573312)


   

SM(d18:1/12:0)

N-lauroyl-D-erythro-Sphingosylphosphoryl choline

C35H71N2O6P (646.5049475999999)


   

Prostaglandin A1-biotin

N-9-oxo-15S-hydroxy-prosta-10,13E-dien-1-oyl-N-biotinoyl-1,6-diaminopentane

C35H58N4O5S (646.4127698)


   

1-(O-alpha-D-glucopyranosyl)-3-keto-(1,27R,29R)-triacontanetriol

1-(O-alpha-D-glucopyranosyl)-3-keto-(1,27R,29R)-triacontanetriol

C36H70O9 (646.5019570000001)


   

1-(O-alpha-D-galactopyranosyl)-3-keto-(1,27R,29R)-triacontanetriol

1-(O-alpha-D-galactopyranosyl)-3-keto-(1,27R,29R)-triacontanetriol

C36H70O9 (646.5019570000001)


   

1-(O-alpha-D-glucopyranosyl)-27-keto-(1,3R,29R)-triacontanetriol

1-(O-alpha-D-glucopyranosyl)-27-keto-(1,3R,29R)-triacontanetriol

C36H70O9 (646.5019570000001)


   

PA(12:0/20:1(11Z))

1-dodecanoyl-2-(11Z-eicosenoyl)-glycero-3-phosphate

C35H67O8P (646.4573312)


   

PA(13:0/19:1(9Z))

1-tridecanoyl-2-(9Z-nonadecenoyl)-glycero-3-phosphate

C35H67O8P (646.4573312)


   

PA(14:1(9Z)/18:0)

1-(9Z-tetradecenoyl)-2-octadecanoyl-glycero-3-phosphate

C35H67O8P (646.4573312)


   

PA(15:0/17:1(9Z))

1-pentadecanoyl-2-(9Z-heptadecenoyl)-glycero-3-phosphate

C35H67O8P (646.4573312)


   

PA(15:1(9Z)/17:0)

1-(9Z-pentadecenoyl)-2-heptadecanoyl-glycero-3-phosphate

C35H67O8P (646.4573312)


   

PA(16:1(9Z)/16:0)

1-(9Z-hexadecenoyl)-2-hexadecanoyl-glycero-3-phosphate

C35H67O8P (646.4573312)


   

PA(17:0/15:1(9Z))

1-heptadecanoyl-2-(9Z-pentadecenoyl)-glycero-3-phosphate

C35H67O8P (646.4573312)


   

PA(17:1(9Z)/15:0)

1-(9Z-heptadecenoyl)-2-pentadecanoyl-glycero-3-phosphate

C35H67O8P (646.4573312)


   

PA(18:0/14:1(9Z))

1-octadecanoyl-2-(9Z-tetradecenoyl)-glycero-3-phosphate

C35H67O8P (646.4573312)


   

PA(19:1(9Z)/13:0)

1-(9Z-nonadecenoyl)-2-tridecanoyl-glycero-3-phosphate

C35H67O8P (646.4573312)


   

PA(20:1(11Z)/12:0)

1-(11Z-eicosenoyl)-2-dodecanoyl-glycero-3-phosphate

C35H67O8P (646.4573312)


   

PA(18:1(9Z)/14:0)

1-(9Z-octadecenoyl)-2-tetradecanoyl-glycero-3-phosphate

C35H67O8P (646.4573312)


   

PA(16:0/16:1(9Z))

1-hexadecanoyl-2-(9Z-hexadecenoyl)-glycero-3-phosphate

C35H67O8P (646.4573312)


   

PA(O-16:0/17:1(9Z))

1-hexadecyl-2-(9Z-heptadecenoyl)-glycero-3-phosphate

C36H71O7P (646.4937146)


   

PA(O-18:0/15:1(9Z))

1-octadecyl-2-(9Z-pentadecenoyl)-glycero-3-phosphate

C36H71O7P (646.4937146)


   

PA(P-16:0/17:0)

1-(1Z-hexadecenyl)-2-heptadecanoyl-glycero-3-phosphate

C36H71O7P (646.4937146)


   

PA(P-18:0/15:0)

1-(1Z-octadecenyl)-2-pentadecanoyl-glycero-3-phosphate

C36H71O7P (646.4937146)


   

PA(P-20:0/13:0)

1-(1Z-eicosenyl)-2-tridecanoyl-glycero-3-phosphate

C36H71O7P (646.4937146)


   

Glycerol 1-(9Z-octadecenoate) 2-tetradecanoate 3-phosphate

{3-[(9E)-octadec-9-enoyloxy]-2-(tetradecanoyloxy)propoxy}phosphonic acid

C35H67O8P (646.4573312)


   

PA 32:1

9-Octadecenoic acid (Z)-, 1-[[(1-oxotetradecyl)oxy]methyl]-2-(phosphonooxy)ethyl ester, (R)-

C35H67O8P (646.4573312)


   

PA O-33:1

1-(1Z-octadecenyl)-2-pentadecanoyl-glycero-3-phosphate

C36H71O7P (646.4937146)


   

SM 30:1;O2

N-lauroyl-D-erythro-Sphingosylphosphoryl choline

C35H71N2O6P (646.5049475999999)


   

CerPE 33:1;O2

N-(octadecanoyl)-pentadecasphing-4-enine-1-phosphoethanolamine

C35H71N2O6P (646.5049475999999)


   

CerPE 32:2;O3

N-(2-hydroxy-octadecanoyl)-4E,6E-tetradecasphingadienine-1-phosphoethanolamine

C34H67N2O7P (646.4685642)


   

Humionoactoside A

(6R,9S)-9-O-beta-D-glucopyranosyloxy-6-O- ([Z,1Z,1Z]-triene)-octadeca-6-hydroxy-9-methyl-3-oxo-alpha-ionol

C37H58O9 (646.4080618)


   

AT-168

Tris(2,4-di-tert-butylphenyl) phosphite

C42H63O3P (646.4514578)


   

butyl 2-methylprop-2-enoate,2-ethylhexyl prop-2-enoate,2-hydroxyethyl prop-2-enoate,methyl 2-methylprop-2-enoate,styrene

butyl 2-methylprop-2-enoate,2-ethylhexyl prop-2-enoate,2-hydroxyethyl prop-2-enoate,methyl 2-methylprop-2-enoate,styrene

C37H58O9 (646.4080618)


   

Fruticoside D

Fruticoside D

C37H58O9 (646.4080618)


A steroid saponin that is 4-methylergosta-7,24(28)-dien-21-oic acid attached to an acetyloxy group at position 2, and a alpha-L-quinovopyranosyloxy group at position 3 (the 2alpha,3beta,4alpha,5alpha stereoisomer). It has been isolated from the roots of Breynia fruticosa.

   

Fruticoside E

Fruticoside E

C37H58O9 (646.4080618)


A steroid saponin that is 4-methylergosta-7,24(28)-dien-21-oic acid attached to an acetyloxy group at position 2, and a alpha-L-rhamnopyranosyloxy group at position 3 (the 2alpha,3beta,4alpha,5alpha stereoisomer). It has been isolated from the roots of Breynia fruticosa.

   

[(E)-2-(dodecanoylamino)-3-hydroxyoctadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(dodecanoylamino)-3-hydroxyoctadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H71N2O6P (646.5049475999999)


   

Dipalmitoyl phosphatidate

Dipalmitoyl phosphatidate

C35H67O8P-2 (646.4573312)


   

3-Demethylubiquinol-7

3-Demethylubiquinol-7

C43H66O4 (646.4960836)


   

Heptaprenylglycerophosphate

Heptaprenylglycerophosphate

C38H63O6P-2 (646.4362028)


   

Dihexadecanoyl phosphatidate(2-)

Dihexadecanoyl phosphatidate(2-)

C35H67O8P-2 (646.4573312)


   

PA(13:0/18:1(12Z)-O(9S,10R))

PA(13:0/18:1(12Z)-O(9S,10R))

C34H63O9P (646.4209478)


   

PA(18:1(12Z)-O(9S,10R)/13:0)

PA(18:1(12Z)-O(9S,10R)/13:0)

C34H63O9P (646.4209478)


   

PA(a-13:0/18:1(12Z)-O(9S,10R))

PA(a-13:0/18:1(12Z)-O(9S,10R))

C34H63O9P (646.4209478)


   

PA(18:1(12Z)-O(9S,10R)/a-13:0)

PA(18:1(12Z)-O(9S,10R)/a-13:0)

C34H63O9P (646.4209478)


   

PA(a-13:0/18:1(9Z)-O(12,13))

PA(a-13:0/18:1(9Z)-O(12,13))

C34H63O9P (646.4209478)


   

PA(18:1(9Z)-O(12,13)/a-13:0)

PA(18:1(9Z)-O(12,13)/a-13:0)

C34H63O9P (646.4209478)


   

PA(i-13:0/18:1(12Z)-O(9S,10R))

PA(i-13:0/18:1(12Z)-O(9S,10R))

C34H63O9P (646.4209478)


   

PA(18:1(12Z)-O(9S,10R)/i-13:0)

PA(18:1(12Z)-O(9S,10R)/i-13:0)

C34H63O9P (646.4209478)


   

PA(i-13:0/18:1(9Z)-O(12,13))

PA(i-13:0/18:1(9Z)-O(12,13))

C34H63O9P (646.4209478)


   

PA(18:1(9Z)-O(12,13)/i-13:0)

PA(18:1(9Z)-O(12,13)/i-13:0)

C34H63O9P (646.4209478)


   

[(2R)-2-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy-3-phosphonooxypropyl] tridecanoate

[(2R)-2-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy-3-phosphonooxypropyl] tridecanoate

C34H63O9P (646.4209478)


   

[(2R)-1-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] tridecanoate

[(2R)-1-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] tridecanoate

C34H63O9P (646.4209478)


   

DG(16:0/PGJ2/0:0)

DG(16:0/PGJ2/0:0)

C39H66O7 (646.4808286)


   

DG(PGJ2/16:0/0:0)

DG(PGJ2/16:0/0:0)

C39H66O7 (646.4808286)


   

DG(16:0/0:0/PGJ2)

DG(16:0/0:0/PGJ2)

C39H66O7 (646.4808286)


   

DG(PGJ2/0:0/16:0)

DG(PGJ2/0:0/16:0)

C39H66O7 (646.4808286)


   

DG(i-16:0/PGJ2/0:0)

DG(i-16:0/PGJ2/0:0)

C39H66O7 (646.4808286)


   

DG(PGJ2/i-16:0/0:0)

DG(PGJ2/i-16:0/0:0)

C39H66O7 (646.4808286)


   

DG(i-16:0/0:0/PGJ2)

DG(i-16:0/0:0/PGJ2)

C39H66O7 (646.4808286)


   

DG(PGJ2/0:0/i-16:0)

DG(PGJ2/0:0/i-16:0)

C39H66O7 (646.4808286)


   

cholesteryl 6-O-hexanoyl-beta-D-galactoside

cholesteryl 6-O-hexanoyl-beta-D-galactoside

C39H66O7 (646.4808286)


A cholesteryl 6-O-acyl-beta-D-galactoside having hexanoyl as the 6-O-acyl group.

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

[1-hydroxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]propan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

[1-hydroxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]propan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C43H66O4 (646.4960836)


   

[1-hydroxy-3-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoxy]propan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

[1-hydroxy-3-[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoxy]propan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C43H66O4 (646.4960836)


   

[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-3-hydroxypropan-2-yl] (6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoate

[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-3-hydroxypropan-2-yl] (6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoate

C43H66O4 (646.4960836)


   

[1-hydroxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propan-2-yl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

[1-hydroxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propan-2-yl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

C43H66O4 (646.4960836)


   

[1-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoxy]-3-hydroxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

[1-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoxy]-3-hydroxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C43H66O4 (646.4960836)


   

[1-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]-3-hydroxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

[1-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]-3-hydroxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C43H66O4 (646.4960836)


   

[1-hydroxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoxy]propan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

[1-hydroxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoxy]propan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C43H66O4 (646.4960836)


   

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propan-2-yl] decanoate

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propan-2-yl] decanoate

C34H63O9P (646.4209478)


   

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propan-2-yl] dodecanoate

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propan-2-yl] dodecanoate

C34H63O9P (646.4209478)


   

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-dodecoxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-dodecoxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C34H63O9P (646.4209478)


   

[1-decoxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

[1-decoxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C34H63O9P (646.4209478)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

[1-Acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tetracosanoate

[1-Acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tetracosanoate

C35H66O10 (646.4655736)


   

[1-Propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tricosanoate

[1-Propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tricosanoate

C35H66O10 (646.4655736)


   

[1-Octanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] octadecanoate

[1-Octanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] octadecanoate

C35H66O10 (646.4655736)


   

[1-Butanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] docosanoate

[1-Butanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] docosanoate

C35H66O10 (646.4655736)


   

[1-Nonanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] heptadecanoate

[1-Nonanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] heptadecanoate

C35H66O10 (646.4655736)


   

[1-Hexanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] icosanoate

[1-Hexanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] icosanoate

C35H66O10 (646.4655736)


   

[1-Heptanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] nonadecanoate

[1-Heptanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] nonadecanoate

C35H66O10 (646.4655736)


   

[1-Pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] henicosanoate

[1-Pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] henicosanoate

C35H66O10 (646.4655736)


   

[2-Tridecanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] tridecanoate

[2-Tridecanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] tridecanoate

C35H66O10 (646.4655736)


   

[1-Decanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] hexadecanoate

[1-Decanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] hexadecanoate

C35H66O10 (646.4655736)


   

[1-[3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-undecanoyloxypropan-2-yl] pentadecanoate

[1-[3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-undecanoyloxypropan-2-yl] pentadecanoate

C35H66O10 (646.4655736)


   

[1-Dodecanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tetradecanoate

[1-Dodecanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tetradecanoate

C35H66O10 (646.4655736)


   

(1-hexanoyloxy-3-phosphonooxypropan-2-yl) (Z)-hexacos-15-enoate

(1-hexanoyloxy-3-phosphonooxypropan-2-yl) (Z)-hexacos-15-enoate

C35H67O8P (646.4573312)


   

(1-octanoyloxy-3-phosphonooxypropan-2-yl) (Z)-tetracos-13-enoate

(1-octanoyloxy-3-phosphonooxypropan-2-yl) (Z)-tetracos-13-enoate

C35H67O8P (646.4573312)


   

[2-[(Z)-pentadec-9-enoyl]oxy-3-phosphonooxypropyl] heptadecanoate

[2-[(Z)-pentadec-9-enoyl]oxy-3-phosphonooxypropyl] heptadecanoate

C35H67O8P (646.4573312)


   

(1-phosphonooxy-3-undecanoyloxypropan-2-yl) (Z)-henicos-11-enoate

(1-phosphonooxy-3-undecanoyloxypropan-2-yl) (Z)-henicos-11-enoate

C35H67O8P (646.4573312)


   

(1-phosphonooxy-3-tetradecanoyloxypropan-2-yl) (Z)-octadec-9-enoate

(1-phosphonooxy-3-tetradecanoyloxypropan-2-yl) (Z)-octadec-9-enoate

C35H67O8P (646.4573312)


   

(1-decanoyloxy-3-phosphonooxypropan-2-yl) (Z)-docos-13-enoate

(1-decanoyloxy-3-phosphonooxypropan-2-yl) (Z)-docos-13-enoate

C35H67O8P (646.4573312)


   

(1-dodecanoyloxy-3-phosphonooxypropan-2-yl) (Z)-icos-11-enoate

(1-dodecanoyloxy-3-phosphonooxypropan-2-yl) (Z)-icos-11-enoate

C35H67O8P (646.4573312)


   

(1-pentadecanoyloxy-3-phosphonooxypropan-2-yl) (Z)-heptadec-9-enoate

(1-pentadecanoyloxy-3-phosphonooxypropan-2-yl) (Z)-heptadec-9-enoate

C35H67O8P (646.4573312)


   

(1-phosphonooxy-3-tridecanoyloxypropan-2-yl) (Z)-nonadec-9-enoate

(1-phosphonooxy-3-tridecanoyloxypropan-2-yl) (Z)-nonadec-9-enoate

C35H67O8P (646.4573312)


   

[3-phosphonooxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] octadecanoate

[3-phosphonooxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] octadecanoate

C35H67O8P (646.4573312)


   

[2-[(Z)-hexadec-9-enoyl]oxy-3-phosphonooxypropyl] hexadecanoate

[2-[(Z)-hexadec-9-enoyl]oxy-3-phosphonooxypropyl] hexadecanoate

C35H67O8P (646.4573312)


   

[3-phosphonooxy-2-[(Z)-tridec-9-enoyl]oxypropyl] nonadecanoate

[3-phosphonooxy-2-[(Z)-tridec-9-enoyl]oxypropyl] nonadecanoate

C35H67O8P (646.4573312)


   

[(2R)-2-[(E)-hexadec-9-enoyl]oxy-3-phosphonooxypropyl] hexadecanoate

[(2R)-2-[(E)-hexadec-9-enoyl]oxy-3-phosphonooxypropyl] hexadecanoate

C35H67O8P (646.4573312)


   

[(2R)-3-phosphonooxy-2-tetradecanoyloxypropyl] (E)-octadec-6-enoate

[(2R)-3-phosphonooxy-2-tetradecanoyloxypropyl] (E)-octadec-6-enoate

C35H67O8P (646.4573312)


   

[1-carboxy-3-[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[(2S)-1-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-undecanoyloxypropan-2-yl] pentadecanoate

[(2S)-1-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-undecanoyloxypropan-2-yl] pentadecanoate

C35H66O10 (646.4655736)


   

[(2R)-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-undecanoyloxypropyl] pentadecanoate

[(2R)-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-undecanoyloxypropyl] pentadecanoate

C35H66O10 (646.4655736)


   

2-[[3-decanoyloxy-2-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-decanoyloxy-2-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H65NO8P+ (646.444756)


   

[(2R)-1-phosphonooxy-3-tetradecanoyloxypropan-2-yl] (E)-octadec-4-enoate

[(2R)-1-phosphonooxy-3-tetradecanoyloxypropan-2-yl] (E)-octadec-4-enoate

C35H67O8P (646.4573312)


   

[1-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-hydroxypropan-2-yl] (5E,8E,11E,14E,17E,20E)-tricosa-5,8,11,14,17,20-hexaenoate

[1-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-hydroxypropan-2-yl] (5E,8E,11E,14E,17E,20E)-tricosa-5,8,11,14,17,20-hexaenoate

C42H62O5 (646.4597001999999)


   

[(2R)-1-phosphonooxy-3-tetradecanoyloxypropan-2-yl] (E)-octadec-13-enoate

[(2R)-1-phosphonooxy-3-tetradecanoyloxypropan-2-yl] (E)-octadec-13-enoate

C35H67O8P (646.4573312)


   

[(2R)-2-[(E)-hexadec-7-enoyl]oxy-3-phosphonooxypropyl] hexadecanoate

[(2R)-2-[(E)-hexadec-7-enoyl]oxy-3-phosphonooxypropyl] hexadecanoate

C35H67O8P (646.4573312)


   

[1-carboxy-3-[2-decanoyloxy-3-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-decanoyloxy-3-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[1-carboxy-3-[2-dodecanoyloxy-3-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-dodecanoyloxy-3-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[(2R)-2-[(E)-pentadec-9-enoyl]oxy-3-phosphonooxypropyl] heptadecanoate

[(2R)-2-[(E)-pentadec-9-enoyl]oxy-3-phosphonooxypropyl] heptadecanoate

C35H67O8P (646.4573312)


   

[(2S)-1-decanoyloxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] hexadecanoate

[(2S)-1-decanoyloxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] hexadecanoate

C35H66O10 (646.4655736)


   

[(2S)-2-dodecanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] tetradecanoate

[(2S)-2-dodecanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] tetradecanoate

C35H66O10 (646.4655736)


   

[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[1-carboxy-3-[2-[(E)-dec-4-enoyl]oxy-3-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-[(E)-dec-4-enoyl]oxy-3-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[1-carboxy-3-[3-[(E)-dodec-5-enoyl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-[(E)-dodec-5-enoyl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[(2R)-2-dodecanoyloxy-3-phosphonooxypropyl] (E)-icos-13-enoate

[(2R)-2-dodecanoyloxy-3-phosphonooxypropyl] (E)-icos-13-enoate

C35H67O8P (646.4573312)


   

[(2S)-1-dodecanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tetradecanoate

[(2S)-1-dodecanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tetradecanoate

C35H66O10 (646.4655736)


   

[1-carboxy-3-[3-[(6E,9E)-dodeca-6,9-dienoyl]oxy-2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-[(6E,9E)-dodeca-6,9-dienoyl]oxy-2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[1-carboxy-3-[2-[(6E,9E)-dodeca-6,9-dienoyl]oxy-3-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-[(6E,9E)-dodeca-6,9-dienoyl]oxy-3-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[(2R)-1-phosphonooxy-3-tetradecanoyloxypropan-2-yl] (E)-octadec-11-enoate

[(2R)-1-phosphonooxy-3-tetradecanoyloxypropan-2-yl] (E)-octadec-11-enoate

C35H67O8P (646.4573312)


   

[(2R)-1-phosphonooxy-3-tetradecanoyloxypropan-2-yl] (E)-octadec-9-enoate

[(2R)-1-phosphonooxy-3-tetradecanoyloxypropan-2-yl] (E)-octadec-9-enoate

C35H67O8P (646.4573312)


   

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (E)-docos-13-enoate

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (E)-docos-13-enoate

C35H67O8P (646.4573312)


   

[1-carboxy-3-[3-[(E)-dec-4-enoyl]oxy-2-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-[(E)-dec-4-enoyl]oxy-2-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[(2R)-1-dodecanoyloxy-3-phosphonooxypropan-2-yl] (E)-icos-11-enoate

[(2R)-1-dodecanoyloxy-3-phosphonooxypropan-2-yl] (E)-icos-11-enoate

C35H67O8P (646.4573312)


   

[1-carboxy-3-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[(2R)-1-pentadecanoyloxy-3-phosphonooxypropan-2-yl] (E)-heptadec-9-enoate

[(2R)-1-pentadecanoyloxy-3-phosphonooxypropan-2-yl] (E)-heptadec-9-enoate

C35H67O8P (646.4573312)


   

[(2R)-3-phosphonooxy-2-tetradecanoyloxypropyl] octadec-17-enoate

[(2R)-3-phosphonooxy-2-tetradecanoyloxypropyl] octadec-17-enoate

C35H67O8P (646.4573312)


   

[(2S)-2-decanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] hexadecanoate

[(2S)-2-decanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] hexadecanoate

C35H66O10 (646.4655736)


   

[(2R)-2-dodecanoyloxy-3-phosphonooxypropyl] (E)-icos-11-enoate

[(2R)-2-dodecanoyloxy-3-phosphonooxypropyl] (E)-icos-11-enoate

C35H67O8P (646.4573312)


   

[(2R)-1-[(E)-pentadec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] heptadecanoate

[(2R)-1-[(E)-pentadec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] heptadecanoate

C35H67O8P (646.4573312)


   

[(2R)-1-dodecanoyloxy-3-phosphonooxypropan-2-yl] (E)-icos-13-enoate

[(2R)-1-dodecanoyloxy-3-phosphonooxypropan-2-yl] (E)-icos-13-enoate

C35H67O8P (646.4573312)


   

[(2R)-1-phosphonooxy-3-tetradecanoyloxypropan-2-yl] octadec-17-enoate

[(2R)-1-phosphonooxy-3-tetradecanoyloxypropan-2-yl] octadec-17-enoate

C35H67O8P (646.4573312)


   

[(2R)-1-phosphonooxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] octadecanoate

[(2R)-1-phosphonooxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] octadecanoate

C35H67O8P (646.4573312)


   

[(2R)-3-phosphonooxy-2-tetradecanoyloxypropyl] (E)-octadec-7-enoate

[(2R)-3-phosphonooxy-2-tetradecanoyloxypropyl] (E)-octadec-7-enoate

C35H67O8P (646.4573312)


   

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (E)-docos-13-enoate

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (E)-docos-13-enoate

C35H67O8P (646.4573312)


   

[(2R)-3-phosphonooxy-2-tetradecanoyloxypropyl] (E)-octadec-13-enoate

[(2R)-3-phosphonooxy-2-tetradecanoyloxypropyl] (E)-octadec-13-enoate

C35H67O8P (646.4573312)


   

[(2R)-1-[(E)-hexadec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] hexadecanoate

[(2R)-1-[(E)-hexadec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] hexadecanoate

C35H67O8P (646.4573312)


   

[1-carboxy-3-[3-decanoyloxy-2-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-decanoyloxy-2-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[(2R)-3-phosphonooxy-2-[(E)-tetradec-9-enoyl]oxypropyl] octadecanoate

[(2R)-3-phosphonooxy-2-[(E)-tetradec-9-enoyl]oxypropyl] octadecanoate

C35H67O8P (646.4573312)


   

[(2R)-2-pentadecanoyloxy-3-phosphonooxypropyl] (E)-heptadec-9-enoate

[(2R)-2-pentadecanoyloxy-3-phosphonooxypropyl] (E)-heptadec-9-enoate

C35H67O8P (646.4573312)


   

[(2R)-3-phosphonooxy-2-tetradecanoyloxypropyl] (E)-octadec-9-enoate

[(2R)-3-phosphonooxy-2-tetradecanoyloxypropyl] (E)-octadec-9-enoate

C35H67O8P (646.4573312)


   

[1-carboxy-3-[3-dodecanoyloxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-dodecanoyloxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[1-carboxy-3-[2-[(E)-dodec-5-enoyl]oxy-3-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-[(E)-dodec-5-enoyl]oxy-3-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[(2R)-1-phosphonooxy-3-tetradecanoyloxypropan-2-yl] (E)-octadec-6-enoate

[(2R)-1-phosphonooxy-3-tetradecanoyloxypropan-2-yl] (E)-octadec-6-enoate

C35H67O8P (646.4573312)


   

[(2R)-3-phosphonooxy-2-tetradecanoyloxypropyl] (E)-octadec-4-enoate

[(2R)-3-phosphonooxy-2-tetradecanoyloxypropyl] (E)-octadec-4-enoate

C35H67O8P (646.4573312)


   

[(2R)-1-[(E)-hexadec-7-enoyl]oxy-3-phosphonooxypropan-2-yl] hexadecanoate

[(2R)-1-[(E)-hexadec-7-enoyl]oxy-3-phosphonooxypropan-2-yl] hexadecanoate

C35H67O8P (646.4573312)


   

[(2R)-1-phosphonooxy-3-tetradecanoyloxypropan-2-yl] (E)-octadec-7-enoate

[(2R)-1-phosphonooxy-3-tetradecanoyloxypropan-2-yl] (E)-octadec-7-enoate

C35H67O8P (646.4573312)


   

[(2S)-2-tridecanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] tridecanoate

[(2S)-2-tridecanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] tridecanoate

C35H66O10 (646.4655736)


   

[(2R)-3-phosphonooxy-2-tetradecanoyloxypropyl] (E)-octadec-11-enoate

[(2R)-3-phosphonooxy-2-tetradecanoyloxypropyl] (E)-octadec-11-enoate

C35H67O8P (646.4573312)


   

[1-carboxy-3-[2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[1-carboxy-3-[3-[(7E,9E)-tetradeca-7,9-dienoyl]oxy-2-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-[(7E,9E)-tetradeca-7,9-dienoyl]oxy-2-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[1-carboxy-3-[2-[(7E,9E)-tetradeca-7,9-dienoyl]oxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-[(7E,9E)-tetradeca-7,9-dienoyl]oxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropan-2-yl] (8E,11E,14E,17E,20E)-tricosa-8,11,14,17,20-pentaenoate

[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropan-2-yl] (8E,11E,14E,17E,20E)-tricosa-8,11,14,17,20-pentaenoate

C42H62O5 (646.4597001999999)


   

[1-carboxy-3-[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-hexanoyloxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-hexanoyloxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

2-[[3-butanoyloxy-2-[(13Z,16Z)-docosa-13,16-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-butanoyloxy-2-[(13Z,16Z)-docosa-13,16-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H65NO8P+ (646.444756)


   

2-[2,3-bis[[(Z)-tridec-9-enoyl]oxy]propoxy-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[2,3-bis[[(Z)-tridec-9-enoyl]oxy]propoxy-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H65NO8P+ (646.444756)


   

[1-carboxy-3-[3-decanoyloxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-decanoyloxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

2-[[3-acetyloxy-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-acetyloxy-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H65NO8P+ (646.444756)


   

2-[[3-decanoyloxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-decanoyloxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H65NO8P+ (646.444756)


   

2-[[3-hexanoyloxy-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-hexanoyloxy-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H65NO8P+ (646.444756)


   

2-[[3-heptanoyloxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-heptanoyloxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H65NO8P+ (646.444756)


   

2-[hydroxy-[3-[(Z)-tetradec-9-enoxy]-2-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-[(Z)-tetradec-9-enoxy]-2-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C35H69NO7P+ (646.4811394)


   

2-[[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-nonanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-nonanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H65NO8P+ (646.444756)


   

2-[[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H65NO8P+ (646.444756)


   

[1-carboxy-3-[2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-octanoyloxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-octanoyloxypropoxy]propyl]-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

2-[hydroxy-[2-nonanoyloxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[2-nonanoyloxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C35H69NO7P+ (646.4811394)


   

2-[hydroxy-[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-octanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-octanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C34H65NO8P+ (646.444756)


   

2-[[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-undecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-undecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H69NO7P+ (646.4811394)


   

2-[carboxy-[2-hydroxy-3-[(10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-10,13,16,19,22,25-hexaenoyl]oxypropoxy]methoxy]ethyl-trimethylazanium

2-[carboxy-[2-hydroxy-3-[(10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-10,13,16,19,22,25-hexaenoyl]oxypropoxy]methoxy]ethyl-trimethylazanium

C38H64NO7+ (646.4682533999999)


   

2-[hydroxy-[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-octoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-octoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C35H69NO7P+ (646.4811394)


   

2-[[3-decoxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-decoxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H69NO7P+ (646.4811394)


   

2-[hydroxy-[3-[(9Z,12Z)-nonadeca-9,12-dienoxy]-2-octanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-[(9Z,12Z)-nonadeca-9,12-dienoxy]-2-octanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C35H69NO7P+ (646.4811394)


   

2-[[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-undecoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-undecoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H69NO7P+ (646.4811394)


   

2-[hydroxy-[2-[(Z)-tetradec-9-enoyl]oxy-3-[(Z)-tridec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[2-[(Z)-tetradec-9-enoyl]oxy-3-[(Z)-tridec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C35H69NO7P+ (646.4811394)


   

2-[[3-[(13Z,16Z)-docosa-13,16-dienoxy]-2-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-[(13Z,16Z)-docosa-13,16-dienoxy]-2-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H69NO7P+ (646.4811394)


   

2-[hydroxy-[3-nonoxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-nonoxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C35H69NO7P+ (646.4811394)


   

2-[hydroxy-[2-propanoyloxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[2-propanoyloxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C35H69NO7P+ (646.4811394)


   

2-[[3-[(11Z,14Z)-henicosa-11,14-dienoxy]-2-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-[(11Z,14Z)-henicosa-11,14-dienoxy]-2-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H69NO7P+ (646.4811394)


   

2-[[2-decanoyloxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-decanoyloxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H69NO7P+ (646.4811394)


   

2-[[2-heptanoyloxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-heptanoyloxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H69NO7P+ (646.4811394)


   

1,2-dihexadecanoyl-sn-glycerol-3-phosphate(2-)

1,2-dihexadecanoyl-sn-glycerol-3-phosphate(2-)

C35H67O8P (646.4573312)


A 1-acyl-2-hexadecanoyl-sn-glycero-3-phosphate(2-) in which the 1-acyl group is also hexadecanoyl; major species at pH 7.3.

   

1-(9Z-hexadecenoyl)-2-hexadecanoyl-glycero-3-phosphate

1-(9Z-hexadecenoyl)-2-hexadecanoyl-glycero-3-phosphate

C35H67O8P (646.4573312)


   

1-octadecanoyl-2-(9Z-tetradecenoyl)-glycero-3-phosphate

1-octadecanoyl-2-(9Z-tetradecenoyl)-glycero-3-phosphate

C35H67O8P (646.4573312)


   

1-(9Z-octadecenoyl)-2-tetradecanoyl-glycero-3-phosphate

1-(9Z-octadecenoyl)-2-tetradecanoyl-glycero-3-phosphate

C35H67O8P (646.4573312)


   

Dihexadecanoyl phosphatidate(2-)

Dihexadecanoyl phosphatidate(2-)

C35H67O8P (646.4573312)


A phosphatidate(2-) obtained by deprotonation of both phosphate OH groups of dihexadecanoylphosphatidic acid; major species at pH 7.3.

   

1-myristoyl-2-oleoyl-sn-glycero-3-phosphate

1-myristoyl-2-oleoyl-sn-glycero-3-phosphate

C35H67O8P (646.4573312)


A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl substituents at positions 1 and 2 are specified as myristoyl and oleoyl respectively.

   

1-(1Z-hexadecenyl)-2-heptadecanoyl-glycero-3-phosphate

1-(1Z-hexadecenyl)-2-heptadecanoyl-glycero-3-phosphate

C36H71O7P (646.4937146)


   

1-hexadecyl-2-(9Z-heptadecenoyl)-glycero-3-phosphate

1-hexadecyl-2-(9Z-heptadecenoyl)-glycero-3-phosphate

C36H71O7P (646.4937146)


   

1-oleoyl-2-myristoyl-sn-glycero-3-phosphate

1-oleoyl-2-myristoyl-sn-glycero-3-phosphate

C35H67O8P (646.4573312)


A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl substituents at positions 1 and 2 are specified as oleoyl and tetradecanoyl respectively.

   

TG(38:10)

TG(6:0_10:4_22:6)

C41H58O6 (646.4233168000001)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(39:10)

TG(18:3(1)_10:4_11:3)

C42H62O5 (646.4597001999999)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

MGDG(27:0)

MGDG(12:0(1)_15:0)

C36H70O9 (646.5019570000001)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

MGMG(27:0)

MGMG(27:0)

C36H70O9 (646.5019570000001)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

BisMePA(30:1)

BisMePA(16:1_14:0)

C35H67O8P (646.4573312)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

MGDG(26:0)

MGDG(12:0_14:0)

C35H66O10 (646.4655736)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

FAHFA 17:2/O-26:7

FAHFA 17:2/O-26:7

C43H66O4 (646.4960836)


   

FAHFA 17:3/O-26:6

FAHFA 17:3/O-26:6

C43H66O4 (646.4960836)


   

FAHFA 17:4/O-26:5

FAHFA 17:4/O-26:5

C43H66O4 (646.4960836)


   

FAHFA 17:5/O-26:4

FAHFA 17:5/O-26:4

C43H66O4 (646.4960836)


   

FAHFA 18:2/O-25:7

FAHFA 18:2/O-25:7

C43H66O4 (646.4960836)


   

FAHFA 18:3/O-25:6

FAHFA 18:3/O-25:6

C43H66O4 (646.4960836)


   

FAHFA 18:4/O-25:5

FAHFA 18:4/O-25:5

C43H66O4 (646.4960836)


   

FAHFA 18:5/O-25:4

FAHFA 18:5/O-25:4

C43H66O4 (646.4960836)


   

FAHFA 18:6/O-25:3

FAHFA 18:6/O-25:3

C43H66O4 (646.4960836)


   

FAHFA 19:2/O-24:7

FAHFA 19:2/O-24:7

C43H66O4 (646.4960836)


   

FAHFA 19:3/O-24:6

FAHFA 19:3/O-24:6

C43H66O4 (646.4960836)


   

FAHFA 19:4/O-24:5

FAHFA 19:4/O-24:5

C43H66O4 (646.4960836)


   

FAHFA 19:5/O-24:4

FAHFA 19:5/O-24:4

C43H66O4 (646.4960836)


   

FAHFA 19:6/O-24:3

FAHFA 19:6/O-24:3

C43H66O4 (646.4960836)


   

FAHFA 20:2/O-23:7

FAHFA 20:2/O-23:7

C43H66O4 (646.4960836)


   

FAHFA 20:3/O-23:6

FAHFA 20:3/O-23:6

C43H66O4 (646.4960836)


   

FAHFA 20:4/O-23:5

FAHFA 20:4/O-23:5

C43H66O4 (646.4960836)


   

FAHFA 20:5/O-23:4

FAHFA 20:5/O-23:4

C43H66O4 (646.4960836)


   

FAHFA 20:6/O-23:3

FAHFA 20:6/O-23:3

C43H66O4 (646.4960836)


   

FAHFA 21:2/O-22:7

FAHFA 21:2/O-22:7

C43H66O4 (646.4960836)


   

FAHFA 21:3/O-22:6

FAHFA 21:3/O-22:6

C43H66O4 (646.4960836)


   

FAHFA 21:4/O-22:5

FAHFA 21:4/O-22:5

C43H66O4 (646.4960836)


   

FAHFA 21:5/O-22:4

FAHFA 21:5/O-22:4

C43H66O4 (646.4960836)


   

FAHFA 21:6/O-22:3

FAHFA 21:6/O-22:3

C43H66O4 (646.4960836)


   

FAHFA 21:7/O-22:2

FAHFA 21:7/O-22:2

C43H66O4 (646.4960836)


   

FAHFA 22:2/O-21:7

FAHFA 22:2/O-21:7

C43H66O4 (646.4960836)


   

FAHFA 22:3/O-21:6

FAHFA 22:3/O-21:6

C43H66O4 (646.4960836)


   

FAHFA 22:4/O-21:5

FAHFA 22:4/O-21:5

C43H66O4 (646.4960836)


   

FAHFA 22:5/O-21:4

FAHFA 22:5/O-21:4

C43H66O4 (646.4960836)


   

FAHFA 22:6/O-21:3

FAHFA 22:6/O-21:3

C43H66O4 (646.4960836)


   

FAHFA 22:7/O-21:2

FAHFA 22:7/O-21:2

C43H66O4 (646.4960836)


   

FAHFA 23:3/O-20:6

FAHFA 23:3/O-20:6

C43H66O4 (646.4960836)


   

FAHFA 23:4/O-20:5

FAHFA 23:4/O-20:5

C43H66O4 (646.4960836)


   

FAHFA 23:5/O-20:4

FAHFA 23:5/O-20:4

C43H66O4 (646.4960836)


   

FAHFA 23:6/O-20:3

FAHFA 23:6/O-20:3

C43H66O4 (646.4960836)


   

FAHFA 23:7/O-20:2

FAHFA 23:7/O-20:2

C43H66O4 (646.4960836)


   

FAHFA 24:3/O-19:6

FAHFA 24:3/O-19:6

C43H66O4 (646.4960836)


   

FAHFA 24:4/O-19:5

FAHFA 24:4/O-19:5

C43H66O4 (646.4960836)


   

FAHFA 24:5/O-19:4

FAHFA 24:5/O-19:4

C43H66O4 (646.4960836)


   

FAHFA 24:6/O-19:3

FAHFA 24:6/O-19:3

C43H66O4 (646.4960836)


   

FAHFA 24:7/O-19:2

FAHFA 24:7/O-19:2

C43H66O4 (646.4960836)


   

FAHFA 25:3/O-18:6

FAHFA 25:3/O-18:6

C43H66O4 (646.4960836)


   

FAHFA 25:4/O-18:5

FAHFA 25:4/O-18:5

C43H66O4 (646.4960836)


   

FAHFA 25:5/O-18:4

FAHFA 25:5/O-18:4

C43H66O4 (646.4960836)


   

FAHFA 25:6/O-18:3

FAHFA 25:6/O-18:3

C43H66O4 (646.4960836)


   

FAHFA 25:7/O-18:2

FAHFA 25:7/O-18:2

C43H66O4 (646.4960836)


   

FAHFA 26:4/O-17:5

FAHFA 26:4/O-17:5

C43H66O4 (646.4960836)


   

FAHFA 26:5/O-17:4

FAHFA 26:5/O-17:4

C43H66O4 (646.4960836)


   

FAHFA 26:6/O-17:3

FAHFA 26:6/O-17:3

C43H66O4 (646.4960836)


   

FAHFA 26:7/O-17:2

FAHFA 26:7/O-17:2

C43H66O4 (646.4960836)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

PA P-14:0/19:0 or PA O-14:1/19:0

PA P-14:0/19:0 or PA O-14:1/19:0

C36H71O7P (646.4937146)


   
   

PA P-16:0/17:0 or PA O-16:1/17:0

PA P-16:0/17:0 or PA O-16:1/17:0

C36H71O7P (646.4937146)


   
   

PA P-18:0/15:0 or PA O-18:1/15:0

PA P-18:0/15:0 or PA O-18:1/15:0

C36H71O7P (646.4937146)


   
   

PA P-20:0/13:0 or PA O-20:1/13:0

PA P-20:0/13:0 or PA O-20:1/13:0

C36H71O7P (646.4937146)


   
   

PA P-22:0/11:0 or PA O-22:1/11:0

PA P-22:0/11:0 or PA O-22:1/11:0

C36H71O7P (646.4937146)


   
   

PA P-33:0 or PA O-33:1

PA P-33:0 or PA O-33:1

C36H71O7P (646.4937146)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

6-{7-[(4-carboxy-3-hydroxy-3-methylbutanoyl)oxy]-5,11-dihydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-methyl-3-methylideneheptanoic acid

6-{7-[(4-carboxy-3-hydroxy-3-methylbutanoyl)oxy]-5,11-dihydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-methyl-3-methylideneheptanoic acid

C37H58O9 (646.4080618)


   

4-[2-(5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)ethyl]-2'-(acetyloxy)-5',9'-dimethyl-15'-oxospiro[cyclohexane-1,14'-tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan]-3-ene-5'-carboxylic acid

4-[2-(5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)ethyl]-2'-(acetyloxy)-5',9'-dimethyl-15'-oxospiro[cyclohexane-1,14'-tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan]-3-ene-5'-carboxylic acid

C42H62O5 (646.4597001999999)


   

3,4,5-trihydroxyoxan-2-yl 2-[7-(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-6-methylhept-4-enoate

3,4,5-trihydroxyoxan-2-yl 2-[7-(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-6-methylhept-4-enoate

C37H58O9 (646.4080618)


   

6-[(4e,6e,12e,14e)-3,9-dihydroxy-6,8,10,14,16,18-hexamethylicosa-4,6,12,14-tetraen-2-yl]-3-[3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-4-hydroxypyran-2-one

6-[(4e,6e,12e,14e)-3,9-dihydroxy-6,8,10,14,16,18-hexamethylicosa-4,6,12,14-tetraen-2-yl]-3-[3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-4-hydroxypyran-2-one

C37H58O9 (646.4080618)


   

1-(2e)-5-[(1r,4ar,8ar)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-3-methylpent-2-en-1-yl (1r,4r,9r,10s,13r,15r)-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl propanedioate

1-(2e)-5-[(1r,4ar,8ar)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-3-methylpent-2-en-1-yl (1r,4r,9r,10s,13r,15r)-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl propanedioate

C43H66O4 (646.4960836)


   

(1r,4s,5s,8r,9r,12s,13s,16s)-8-[(2r,4e)-6-methoxy-6-methylhept-4-en-2-yl]-5,9,17,17-tetramethyl-16-{[(2r,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-18-oxapentacyclo[10.5.2.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-2-en-19-one

(1r,4s,5s,8r,9r,12s,13s,16s)-8-[(2r,4e)-6-methoxy-6-methylhept-4-en-2-yl]-5,9,17,17-tetramethyl-16-{[(2r,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-18-oxapentacyclo[10.5.2.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-2-en-19-one

C37H58O9 (646.4080618)


   

(4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-{[(2s,3r,4s,5s)-4-(acetyloxy)-3,5-dihydroxyoxan-2-yl]oxy}-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

(4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-{[(2s,3r,4s,5s)-4-(acetyloxy)-3,5-dihydroxyoxan-2-yl]oxy}-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C37H58O9 (646.4080618)


   

3-[2-(5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)ethyl]-2'-(acetyloxy)-5',9'-dimethyl-15'-oxospiro[cyclohexane-1,14'-tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan]-3-ene-5'-carboxylic acid

3-[2-(5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)ethyl]-2'-(acetyloxy)-5',9'-dimethyl-15'-oxospiro[cyclohexane-1,14'-tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan]-3-ene-5'-carboxylic acid

C42H62O5 (646.4597001999999)


   

6-[(4e,6e,12e,14e)-3,9-dihydroxy-6,8,10,14,16,18-hexamethylicosa-4,6,12,14-tetraen-2-yl]-3-[3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-2-hydroxypyran-4-one

6-[(4e,6e,12e,14e)-3,9-dihydroxy-6,8,10,14,16,18-hexamethylicosa-4,6,12,14-tetraen-2-yl]-3-[3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-2-hydroxypyran-4-one

C37H58O9 (646.4080618)


   

6-[(2r,3s,4e,6e,8r,9r,10s,12e,14z,16s,18r)-3,9-dihydroxy-6,8,10,14,16,18-hexamethylicosa-4,6,12,14-tetraen-2-yl]-3-[(2r,3s,4r,6r)-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-4-hydroxypyran-2-one

6-[(2r,3s,4e,6e,8r,9r,10s,12e,14z,16s,18r)-3,9-dihydroxy-6,8,10,14,16,18-hexamethylicosa-4,6,12,14-tetraen-2-yl]-3-[(2r,3s,4r,6r)-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-4-hydroxypyran-2-one

C37H58O9 (646.4080618)


   

2-(3a,6,6,9a,11a-pentamethyl-7-oxo-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl)-6-methyl-5-methylideneheptanoic acid

2-(3a,6,6,9a,11a-pentamethyl-7-oxo-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl)-6-methyl-5-methylideneheptanoic acid

C37H58O9 (646.4080618)


   

(1r,3r,3as,5ar,7s,11ar)-7-{[(2r,3r,4r,5s,6s)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}-3-hydroxy-9a,11a-dimethyl-1-[(2r)-6-methyl-5-methylideneheptan-2-yl]-6-methylidene-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene-3a-carboxylic acid

(1r,3r,3as,5ar,7s,11ar)-7-{[(2r,3r,4r,5s,6s)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}-3-hydroxy-9a,11a-dimethyl-1-[(2r)-6-methyl-5-methylideneheptan-2-yl]-6-methylidene-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene-3a-carboxylic acid

C37H58O9 (646.4080618)


   

2,6,13,17,17-pentamethyl-6-(4-methylpentyl)-8-oxo-16-[(3,4,5-trihydroxyoxan-2-yl)oxy]-7-oxapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icos-1(20)-en-4-yl acetate

2,6,13,17,17-pentamethyl-6-(4-methylpentyl)-8-oxo-16-[(3,4,5-trihydroxyoxan-2-yl)oxy]-7-oxapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icos-1(20)-en-4-yl acetate

C37H58O9 (646.4080618)


   

1-[5-(5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)-3-methylpent-2-en-1-yl] 5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl propanedioate

1-[5-(5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)-3-methylpent-2-en-1-yl] 5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl propanedioate

C43H66O4 (646.4960836)


   

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2r)-2-[(3r,3ar,6s,7s,9br)-6-(3-methoxy-3-oxopropyl)-3a,6,9b-trimethyl-7-(prop-1-en-2-yl)-1h,2h,3h,4h,5h,7h,8h,9h-cyclopenta[a]naphthalen-3-yl]-6-methylhept-5-enoate

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2r)-2-[(3r,3ar,6s,7s,9br)-6-(3-methoxy-3-oxopropyl)-3a,6,9b-trimethyl-7-(prop-1-en-2-yl)-1h,2h,3h,4h,5h,7h,8h,9h-cyclopenta[a]naphthalen-3-yl]-6-methylhept-5-enoate

C37H58O9 (646.4080618)


   

(27s,29r)-27,29-dihydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}triacontan-3-one

(27s,29r)-27,29-dihydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}triacontan-3-one

C36H70O9 (646.5019570000001)


   

6-{7-[(4-carboxy-3-hydroxy-3-methylbutanoyl)oxy]-11-hydroxy-6-(hydroxymethyl)-3a,6,9a,11a-tetramethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-methyl-3-methylideneheptanoic acid

6-{7-[(4-carboxy-3-hydroxy-3-methylbutanoyl)oxy]-11-hydroxy-6-(hydroxymethyl)-3a,6,9a,11a-tetramethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-methyl-3-methylideneheptanoic acid

C37H58O9 (646.4080618)


   

(1r,3r,3as,5ar,7s,9as,11ar)-7-{[(2r,3r,4r,5s,6s)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}-3-hydroxy-9a,11a-dimethyl-1-[(2r)-6-methyl-5-methylideneheptan-2-yl]-6-methylidene-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene-3a-carboxylic acid

(1r,3r,3as,5ar,7s,9as,11ar)-7-{[(2r,3r,4r,5s,6s)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}-3-hydroxy-9a,11a-dimethyl-1-[(2r)-6-methyl-5-methylideneheptan-2-yl]-6-methylidene-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene-3a-carboxylic acid

C37H58O9 (646.4080618)


   

10-{[4-(acetyloxy)-3,5-dihydroxyoxan-2-yl]oxy}-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

10-{[4-(acetyloxy)-3,5-dihydroxyoxan-2-yl]oxy}-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C37H58O9 (646.4080618)


   

(2s,6r)-6-[(1r,3as,5ar,6s,7r,9as,11s,11ar)-7-[(4-carboxy-3-hydroxy-3-methylbutanoyl)oxy]-11-hydroxy-6-(hydroxymethyl)-3a,6,9a,11a-tetramethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

(2s,6r)-6-[(1r,3as,5ar,6s,7r,9as,11s,11ar)-7-[(4-carboxy-3-hydroxy-3-methylbutanoyl)oxy]-11-hydroxy-6-(hydroxymethyl)-3a,6,9a,11a-tetramethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

C37H58O9 (646.4080618)


   

8-(6-methoxy-6-methylhept-4-en-2-yl)-5,9,17,17-tetramethyl-16-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-18-oxapentacyclo[10.5.2.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-2-en-19-one

8-(6-methoxy-6-methylhept-4-en-2-yl)-5,9,17,17-tetramethyl-16-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-18-oxapentacyclo[10.5.2.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-2-en-19-one

C37H58O9 (646.4080618)


   

(3e,5z,7r,8s,9s,11z,13z,15s,16r)-16-[(2s,3r,4s)-4-[(2r,4r,5s,6r)-2,4-dihydroxy-5-methyl-6-[(1e,3e)-penta-1,3-dien-1-yl]oxan-2-yl]-3-hydroxypentan-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

(3e,5z,7r,8s,9s,11z,13z,15s,16r)-16-[(2s,3r,4s)-4-[(2r,4r,5s,6r)-2,4-dihydroxy-5-methyl-6-[(1e,3e)-penta-1,3-dien-1-yl]oxan-2-yl]-3-hydroxypentan-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C37H58O9 (646.4080618)


   

(4as,6as,6br,8ar,10s,12ar,12br,14bs)-2,2,6a,6b,9,9,12a-heptamethyl-10-{[(2r,3r,4s,5s,6s)-3,4,5-trihydroxy-6-(methoxycarbonyl)oxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

(4as,6as,6br,8ar,10s,12ar,12br,14bs)-2,2,6a,6b,9,9,12a-heptamethyl-10-{[(2r,3r,4s,5s,6s)-3,4,5-trihydroxy-6-(methoxycarbonyl)oxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C37H58O9 (646.4080618)


   

(1s,2r,4as,6as,6br,8ar,10s,12ar,12br,14bs)-1,2,6a,6b,9,9,12a-heptamethyl-10-{[3,4,5-trihydroxy-6-(methoxycarbonyl)oxan-2-yl]oxy}-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

(1s,2r,4as,6as,6br,8ar,10s,12ar,12br,14bs)-1,2,6a,6b,9,9,12a-heptamethyl-10-{[3,4,5-trihydroxy-6-(methoxycarbonyl)oxan-2-yl]oxy}-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C37H58O9 (646.4080618)


   

(2r)-2-[(1r,3ar,4r,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

(2r)-2-[(1r,3ar,4r,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

C37H58O9 (646.4080618)


   

(4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-{[(2s,3r,4s,5s)-3-(acetyloxy)-4,5-dihydroxyoxan-2-yl]oxy}-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

(4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-{[(2s,3r,4s,5s)-3-(acetyloxy)-4,5-dihydroxyoxan-2-yl]oxy}-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C37H58O9 (646.4080618)


   

(1s,1'r,2's,4's,5'r,9's,10's,13'r)-3-{2-[(1r,4ar,8ar)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]ethyl}-2'-(acetyloxy)-5',9'-dimethyl-15'-oxospiro[cyclohexane-1,14'-tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan]-3-ene-5'-carboxylic acid

(1s,1'r,2's,4's,5'r,9's,10's,13'r)-3-{2-[(1r,4ar,8ar)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]ethyl}-2'-(acetyloxy)-5',9'-dimethyl-15'-oxospiro[cyclohexane-1,14'-tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan]-3-ene-5'-carboxylic acid

C42H62O5 (646.4597001999999)


   

(2s,6r)-6-[(1r,3as,5r,5ar,7s,9as,11s,11ar)-7-{[(3s)-4-carboxy-3-hydroxy-3-methylbutanoyl]oxy}-5,11-dihydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

(2s,6r)-6-[(1r,3as,5r,5ar,7s,9as,11s,11ar)-7-{[(3s)-4-carboxy-3-hydroxy-3-methylbutanoyl]oxy}-5,11-dihydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

C37H58O9 (646.4080618)


   

(6-{[(1r,7s,9ar,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl butanoate

(6-{[(1r,7s,9ar,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl butanoate

C39H66O7 (646.4808286)


   

1,2,6a,6b,9,9,12a-heptamethyl-10-{[3,4,5-trihydroxy-6-(methoxycarbonyl)oxan-2-yl]oxy}-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

1,2,6a,6b,9,9,12a-heptamethyl-10-{[3,4,5-trihydroxy-6-(methoxycarbonyl)oxan-2-yl]oxy}-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C37H58O9 (646.4080618)


   

6-(3,9-dihydroxy-6,8,10,14,16,18-hexamethylicosa-4,6,12,14-tetraen-2-yl)-3-[3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-4-hydroxypyran-2-one

6-(3,9-dihydroxy-6,8,10,14,16,18-hexamethylicosa-4,6,12,14-tetraen-2-yl)-3-[3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-4-hydroxypyran-2-one

C37H58O9 (646.4080618)


   

(2s,6r)-6-[(1r,3as,5ar,6s,7r,9as,11s,11ar)-7-{[(3s)-4-carboxy-3-hydroxy-3-methylbutanoyl]oxy}-11-hydroxy-6-(hydroxymethyl)-3a,6,9a,11a-tetramethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

(2s,6r)-6-[(1r,3as,5ar,6s,7r,9as,11s,11ar)-7-{[(3s)-4-carboxy-3-hydroxy-3-methylbutanoyl]oxy}-11-hydroxy-6-(hydroxymethyl)-3a,6,9a,11a-tetramethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

C37H58O9 (646.4080618)


   

10-{[5-(acetyloxy)-3,4-dihydroxyoxan-2-yl]oxy}-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

10-{[5-(acetyloxy)-3,4-dihydroxyoxan-2-yl]oxy}-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C37H58O9 (646.4080618)


   

(2r)-2-[(1r,3ar,4s,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

(2r)-2-[(1r,3ar,4s,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

C37H58O9 (646.4080618)


   

(1r,4s,5s,8r,9r,12s,13s,16s)-8-[(2r,4e)-6-methoxy-6-methylhept-4-en-2-yl]-5,9,17,17-tetramethyl-16-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-18-oxapentacyclo[10.5.2.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-2-en-19-one

(1r,4s,5s,8r,9r,12s,13s,16s)-8-[(2r,4e)-6-methoxy-6-methylhept-4-en-2-yl]-5,9,17,17-tetramethyl-16-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-18-oxapentacyclo[10.5.2.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-2-en-19-one

C37H58O9 (646.4080618)


   

(1s,2r,4as,6as,6br,8ar,10s,12ar,12br,14bs)-1,2,6a,6b,9,9,12a-heptamethyl-10-{[(2r,3r,4s,5s,6s)-3,4,5-trihydroxy-6-(methoxycarbonyl)oxan-2-yl]oxy}-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

(1s,2r,4as,6as,6br,8ar,10s,12ar,12br,14bs)-1,2,6a,6b,9,9,12a-heptamethyl-10-{[(2r,3r,4s,5s,6s)-3,4,5-trihydroxy-6-(methoxycarbonyl)oxan-2-yl]oxy}-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C37H58O9 (646.4080618)


   

2,4,5-trihydroxyoxan-3-yl 2-[7-(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-6-methylhept-4-enoate

2,4,5-trihydroxyoxan-3-yl 2-[7-(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-6-methylhept-4-enoate

C37H58O9 (646.4080618)


   

10-{[3-(acetyloxy)-4,5-dihydroxyoxan-2-yl]oxy}-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

10-{[3-(acetyloxy)-4,5-dihydroxyoxan-2-yl]oxy}-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C37H58O9 (646.4080618)


   

(1r,3r,3as,5ar,7s,9as,11ar)-7-{[(2r,3s,4s,5r,6s)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}-3-hydroxy-9a,11a-dimethyl-1-[(2r)-6-methyl-5-methylideneheptan-2-yl]-6-methylidene-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene-3a-carboxylic acid

(1r,3r,3as,5ar,7s,9as,11ar)-7-{[(2r,3s,4s,5r,6s)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}-3-hydroxy-9a,11a-dimethyl-1-[(2r)-6-methyl-5-methylideneheptan-2-yl]-6-methylidene-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene-3a-carboxylic acid

C37H58O9 (646.4080618)


   

(1r,3r,3as,5ar,7s,9as,11ar)-7-{[(2s,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}-3-hydroxy-9a,11a-dimethyl-1-[(2s)-6-methyl-5-methylideneheptan-2-yl]-6-methylidene-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene-3a-carboxylic acid

(1r,3r,3as,5ar,7s,9as,11ar)-7-{[(2s,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}-3-hydroxy-9a,11a-dimethyl-1-[(2s)-6-methyl-5-methylideneheptan-2-yl]-6-methylidene-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene-3a-carboxylic acid

C37H58O9 (646.4080618)


   

2,2,6a,6b,9,9,12a-heptamethyl-10-{[3,4,5-trihydroxy-6-(methoxycarbonyl)oxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

2,2,6a,6b,9,9,12a-heptamethyl-10-{[3,4,5-trihydroxy-6-(methoxycarbonyl)oxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C37H58O9 (646.4080618)


   

(1s,1'r,2's,4's,5'r,9's,10's,13'r)-4-{2-[(1r,4ar,8ar)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]ethyl}-2'-(acetyloxy)-5',9'-dimethyl-15'-oxospiro[cyclohexane-1,14'-tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan]-3-ene-5'-carboxylic acid

(1s,1'r,2's,4's,5'r,9's,10's,13'r)-4-{2-[(1r,4ar,8ar)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]ethyl}-2'-(acetyloxy)-5',9'-dimethyl-15'-oxospiro[cyclohexane-1,14'-tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan]-3-ene-5'-carboxylic acid

C42H62O5 (646.4597001999999)


   

(2s,4s,5r,6s,9s,12r,13r,16s,18r)-2,6,13,17,17-pentamethyl-6-(4-methylpentyl)-8-oxo-16-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-7-oxapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icos-1(20)-en-4-yl acetate

(2s,4s,5r,6s,9s,12r,13r,16s,18r)-2,6,13,17,17-pentamethyl-6-(4-methylpentyl)-8-oxo-16-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-7-oxapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icos-1(20)-en-4-yl acetate

C37H58O9 (646.4080618)


   

(2r,3r,4s,5r)-2,4,5-trihydroxyoxan-3-yl (2r,4e)-2-[(1r,3ar,5ar,7r,9as,11ar)-7-(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-6-methylhept-4-enoate

(2r,3r,4s,5r)-2,4,5-trihydroxyoxan-3-yl (2r,4e)-2-[(1r,3ar,5ar,7r,9as,11ar)-7-(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-6-methylhept-4-enoate

C37H58O9 (646.4080618)


   

27,29-dihydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}triacontan-3-one

27,29-dihydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}triacontan-3-one

C36H70O9 (646.5019570000001)


   

(2s,6r)-6-[(1r,3as,5ar,6s,7r,9as,11s,11ar)-7-{[(3r)-4-carboxy-3-hydroxy-3-methylbutanoyl]oxy}-11-hydroxy-6-(hydroxymethyl)-3a,6,9a,11a-tetramethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

(2s,6r)-6-[(1r,3as,5ar,6s,7r,9as,11s,11ar)-7-{[(3r)-4-carboxy-3-hydroxy-3-methylbutanoyl]oxy}-11-hydroxy-6-(hydroxymethyl)-3a,6,9a,11a-tetramethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

C37H58O9 (646.4080618)


   

16-{4-[2,4-dihydroxy-5-methyl-6-(penta-1,3-dien-1-yl)oxan-2-yl]-3-hydroxypentan-2-yl}-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

16-{4-[2,4-dihydroxy-5-methyl-6-(penta-1,3-dien-1-yl)oxan-2-yl]-3-hydroxypentan-2-yl}-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C37H58O9 (646.4080618)


   

7-{[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}-3-hydroxy-9a,11a-dimethyl-1-(6-methyl-5-methylideneheptan-2-yl)-6-methylidene-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene-3a-carboxylic acid

7-{[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}-3-hydroxy-9a,11a-dimethyl-1-(6-methyl-5-methylideneheptan-2-yl)-6-methylidene-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene-3a-carboxylic acid

C37H58O9 (646.4080618)


   

methyl (2s,3s,4s,5r,6r)-6-{[(3s,4ar,6ar,6bs,7r,8as,12as,14ar,14br)-7-hydroxy-4,4,6a,6b,8a,11,11,14b-octamethyl-8-oxo-2,3,4a,5,6,7,9,10,12,12a,14,14a-dodecahydro-1h-picen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylate

methyl (2s,3s,4s,5r,6r)-6-{[(3s,4ar,6ar,6bs,7r,8as,12as,14ar,14br)-7-hydroxy-4,4,6a,6b,8a,11,11,14b-octamethyl-8-oxo-2,3,4a,5,6,7,9,10,12,12a,14,14a-dodecahydro-1h-picen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylate

C37H58O9 (646.4080618)


   

(4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-{[(2s,3r,4r,5s)-5-(acetyloxy)-3,4-dihydroxyoxan-2-yl]oxy}-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

(4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-{[(2s,3r,4r,5s)-5-(acetyloxy)-3,4-dihydroxyoxan-2-yl]oxy}-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C37H58O9 (646.4080618)


   

(2r)-2-[(1r,3ar,4r,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

(2r)-2-[(1r,3ar,4r,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

C37H58O9 (646.4080618)


   

2-[(1r,3s,4s,7r,9s,12r,14s,17r,18r,19r,21r,22s)-3,8,8,17,19-pentamethyl-9-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracosan-22-yl]propan-2-yl acetate

2-[(1r,3s,4s,7r,9s,12r,14s,17r,18r,19r,21r,22s)-3,8,8,17,19-pentamethyl-9-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracosan-22-yl]propan-2-yl acetate

C37H58O9 (646.4080618)